Physician profile
Sohail Kayani
NPI 1700855095
$4,798.01
in general payments reported to CMS, 2019-2025
8 companies · $850 in 2025
The $850 reported for 2025 was more than what 86% of Pediatric Pulmonology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $30.90 · 2021: $802 · 2022: $948 · 2023: $816 · 2024: $778 · 2025: $850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,443 · Education: $0.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,443.27 |
| Education | $0.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,865.57 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Genzyme Corporation | $527.16 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $506.00 | 2021-2023 | Dupixent |
| Amgen INC. | $375.60 | 2022-2025 | Tezspire |
| Glaxosmithkline, LLC. | $268.19 | 2019-2025 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.48 | 2019 | |
| Phadia US INC. | $18.82 | 2024 | Immunocap |
| Ars Pharmaceuticals Operations, INC. | $15.19 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sohail Kayani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.